Glass House Brands GLAS
NYSE GLAS
$9.79 +0.27 (+2.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026)

Glass House Brands (GLAS) posted quarterly Net Equity Issued and Repurchased of $22.3 million for Q1 2026, up 104.61% quarter-over-quarter from $10.9 million in Q3 2023.

Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $22.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $22.3 million; the TTM figure through Mar 2026 stood at $33.5 million (changed N/A YoY), while the FY2022 annual figure was $303694.0, down 99.76% from the prior year.
  • Net Equity Issued and Repurchased advanced to $22.3 million in Q1 2026 per GLAS's latest filing, from $10.9 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $22.3 million in Q1 2026 and bottomed at -$19.2 million in Q4 2022.
  • Historically, Net Equity Issued and Repurchased has averaged $2.9 million across 3 years, with a median of $300000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased slumped 4318.51% — and 2023, when it soared 200.31%.
  • Glass House Brands' Net Equity Issued and Repurchased stood at -$19.2 million in 2022, then surged by 156.78% to $10.9 million in 2023, then surged by 104.61% to $22.3 million in 2026.
  • Business Quant data shows GLAS's Net Equity Issued and Repurchased at $22.3 million in Q1 2026, $10.9 million in Q3 2023, and $300000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Glass House Brands 866.27 Mn 847.71 Mn 15.77 Mn 4.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.30 Mn
Mar 31, 2026 22.30 Mn
Sep 30, 2023 10.90 Mn
Sep 30, 2023 10.90 Mn
Mar 31, 2023 300,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 -19.20 Mn
Dec 31, 2022 -19.20 Mn
Mar 31, 2022 99,898.00
Mar 31, 2022 99,898.00
Dec 31, 2021 455,054.00
Dec 31, 2021 455,054.00
Sep 30, 2021 1.00 Mn
Sep 30, 2021 1.00 Mn